1. Our vision
  2. EMEA News


Displaying 1 - 10 of 37
Tue 15 December 2020
New data from a qualitative survey of glaucoma patients conducted by Santen EMEA in the UK, Spain, Italy and Germany shine new light on the reality of disease management for patients.
Tue 8 December 2020
08 December 2020 – Geneva, Switzerland – Santen EMEA is delighted to be taking part in the European Glaucoma Society’s (EGS) 2020 virtual congress.
Thu 8 October 2020
Santen is delighted to announce the launch of the Re-SOLVE Antibiotic Resist
Thu 8 October 2020
Santen EMEA is proud to support World Sight Day (WSD) 2020, an annual
Thu 17 September 2020
Santen is proud to release its annual Santen Report 2020 to mark the end of fiscal year 2019 and introduce its ne
Wed 16 September 2020
Santen recently announced the acquisition of Eyevance, a US-based ophthalmology company, specialised in the development and commercialisation of topical ophthalmic products targeting the ocular sur
Tue 30 June 2020
As COVID-19 continues to impact hundreds of thousands of people across the world, many healthcare systems are struggling to cope with the strain imposed by the virus. 
Thu 28 May 2020
Santen EMEA and NTC, an international pharmaceutical company headquartered in Italy with expertise in research and development, are delighted to announce the completion and positive outcome of
Thu 28 May 2020
As a healthcare company that is well represented across the globe. Santen’s mission is to contribute to the well-being of patients, their loved ones and consequently to society.